Michael Panzara

Track

Insider profile

Currently holds a position at WAVE Life Sciences Ltd

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Medical Officer WAVE Life Sciences Ltd Nov. 1, 2018 -
Franchise Lead, Neurology WAVE Life Sciences Ltd July 1, 2016 - Oct. 1, 2018
Michael Panzara's trades of WAVE Life Sciences Ltd's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
363.68
Quantity 20,482 -30.5%
Value US$2,441,831
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-06 2022-05-05
PlS Planned sale
55,745 +24.8%
480.99
US$4,116,723 		55,745 +24.8% 480.99 US$4,116,723
2022-02-18 2022-02-16
S Sale
88,387 +39.7%
355.35
US$4,355,244 		88,387 +39.7% 355.35 US$4,355,244
2021-02-18 2021-02-16
PlS Planned sale
20,482 -30.5%
363.68
US$2,441,831 		20,482 -30.5% 363.68 US$2,441,831
2020-02-20 2020-02-18
PlS Planned sale
2,981 -7.0%
7.85
US$23,401 		2,981 -7.0% 7.85 US$23,401
2019-07-09 2019-07-05
PlS Planned sale
445 -1.0%
27.26
US$12,131 		445 -1.0% 27.26 US$12,131
2019-07-09 2019-07-05
PlS Planned sale
2,613 -5.8%
26.88
US$70,237 		2,613 -5.8% 26.88 US$70,237
2019-03-11 2019-03-11
PlS Planned sale
7,000 -13.4%
48.00
US$336,000 		7,000 -13.4% 48.00 US$336,000
2019-02-21 2019-02-19
PlS Planned sale
1,837 -4.7%
36.84
US$67,674 		1,837 -4.7% 36.84 US$67,674
2018-02-21 2018-02-16
PlS Planned sale
511 -1.3%
52.10
US$26,623 		511 -1.3% 52.10 US$26,623
2017-07-13 2017-07-12
PlS Planned sale
7,414 -32.6%
16.67
US$123,620 		7,414 -32.6% 16.67 US$123,620